Vancomycin-resistant enterococcal bacteremia

Common Name(s)

Vancomycin-resistant enterococcal bacteremia

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Vancomycin-resistant enterococcal bacteremia" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Vancomycin-resistant enterococcal bacteremia" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Vancomycin-resistant enterococcal bacteremia" returned 3 free, full-text research articles on human participants. First 3 results:

The emergence of vancomycin-resistant enterococcal bacteremia in hematopoietic stem cell transplant recipients.
 

Author(s): Michael J Satlin, Rosemary Soave, Alexandra C Racanelli, Tsiporah B Shore, Koen van Besien, Stephen G Jenkins, Thomas J Walsh

Journal: Leuk. Lymphoma. 2014 Dec;55(12):2858-65.

 

Abstract As antimicrobial resistance increases, understanding the current epidemiology of bloodstream infections (BSIs) in hematopoietic stem cell transplant (HSCT) recipients is essential to guide empirical antimicrobial therapy. We therefore reviewed microbial etiologies, timing ...

Last Updated: 18 Dec 2014

Go To URL
Vancomycin-resistant enterococcal bacteremia in a hematology unit: molecular epidemiology and analysis of clinical course.
 

Author(s): Jin-Hong Yoo, Dong-Gun Lee, Su Mi Choi, Jung-Hyun Choi, Wan-Shik Shin, Myungshin Kim, Dongeun Yong, Kyungwon Lee, Woo-Sung Min, Chun-Choo Kim

Journal: J. Korean Med. Sci.. 2005 Apr;20(2):169-76.

 

An increase in vancomycin-resistant enterococcal (VRE) bacteremia in hemato-oncological patients (n=19) in our institution from 2000 through 2001 led us to analyze the molecular epidemiologic patterns and clinical features unique to our cases. The pulsed field gel electrophoresis ...

Last Updated: 15 Apr 2005

Go To URL
Incidence and outcome of vancomycin-resistant enterococcal bacteremia following autologous peripheral blood stem cell transplantation.
 

Author(s): D Kapur, D Dorsky, J M Feingold, R D Bona, R L Edwards, J Aslanzadeh, P J Tutschka, S Bilgrami

Journal: Bone Marrow Transplant.. 2000 Jan;25(2):147-52.

 

A retrospective evaluation of 321 consecutive recipients of high-dose chemotherapy (HDC) and autologous peripheral blood stem cell transplantation (PBSCT) was conducted to ascertain the incidence and outcome of vancomycin-resistant enterococcal (VRE) bacteremia. Ten patients developed ...

Last Updated: 20 Mar 2000

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Vancomycin-resistant enterococcal bacteremia" returned 2 free, full-text review articles on human participants. First 3 results:

Daptomycin versus linezolid for treatment of vancomycin-resistant enterococcal bacteremia: systematic review and meta-analysis.
 

Author(s): Yu-Chung Chuang, Jann-Tay Wang, Hsin-Yi Lin, Shan-Chwen Chang

Journal:

 

Linezolid, which has bacteriostatic activity, is approved for the treatment of vancomycin-resistant enterococci (VRE) infections. Meanwhile, daptomycin exerts bactericidal activity against VRE, but is not approved for the treatment of VRE bacteremia. Only a few studies with small ...

Last Updated: 18 Dec 2014

Go To URL
Systematic review and meta-analysis of linezolid versus daptomycin for treatment of vancomycin-resistant enterococcal bacteremia.
 

Author(s): Eleni P Balli, Chris A Venetis, Spiros Miyakis

Journal: Antimicrob. Agents Chemother.. 2014 ;58(2):734-9.

 

Limited therapeutic options exist for the treatment of vancomycin-resistant Enterococcus (VRE) bacteremia; the most commonly used are daptomycin and linezolid. We attempted a systematic review and meta-analysis of the comparative efficacy of those two agents. Studies comparing daptomycin ...

Last Updated: 28 Jan 2014

Go To URL
 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

There are currently no open clinical trials for this condition.